Dr. Trotter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 860
Dallas, TX 75246Phone+1 214-820-8500Fax+1 214-820-8168
Education & Training
Duke University HospitalFellowship, Gastroenterology, 1992 - 1996
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1992
Emory University School of MedicineClass of 1989
Certifications & Licensure
MT State Medical License 2024 - 2026
UT State Medical License 2023 - 2026
CO State Medical License 2024 - 2025
ID State Medical License 2024 - 2025
NV State Medical License 2024 - 2025
TX State Medical License 1992 - 2025
NC State Medical License 1996 - 2000- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Start of enrollment: 2006 May 01
- Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery Start of enrollment: 2013 Jun 01
- A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation.Lianne M Nieuwenhuis, Yanni Li, Bao-Li Loza, Annechien J A Lambeck, Shixian Hu
Hepatology Communications. 2025-01-01 - Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates.Stevan A Gonzalez, Nagasri Shankar, Ashwini Mehta, Mauricio Garcia-Saenz-de-Sicilia, Goran B Klintmalm
Liver Transplantation. 2024-09-24 - 35 citationsResults from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.Arun J Sanyal, Vlad Ratziu, Rohit Loomba, Quentin M Anstee, Kris V Kowdley
Journal of Hepatology. 2023-11-01
Journal Articles
- Impact of Prior Bariatric Surgery on Perioperative Liver Transplant OutcomesSumeet K Asrani, James Trotter, Goran Klintmalm, Liver transplantation
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
- Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based StudySumeet K Asrani, James Trotter, Jayant Talwalkar, Fasiha Kanwal, Nature
Press Mentions
Why CDC Wants More People Screened for Hepatitis CJuly 26th, 2020- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationJuly 23rd, 2020
Transplantation and Undocumented Immigrants: A Tale of Two StatesSeptember 26th, 2019- Join now to see all
Grant Support
- Phase II Trial Assess Sfty Of Imnosprsn W/Drawal In Liver Trnsplnt Recip W/Hep CNational Center For Research Resources2006–2008
- Campth-1h&Tacrolimus Followed By Immunosuppress Withdrawal In Liver TransplantsNational Center For Research Resources2006–2008
- A2all: Adult-To-Adult Living Donor Liver Transplant Cohort StudyNational Center For Research Resources2006–2008
- Adult To Adult Living Donor Liver Transplantation Cohor*National Institute Of Diabetes And Digestive And Kidney Diseases2002–2008
- Treatment Of Chronic Hepatitis C: Peg-Intron And Ribavirin With Or Without KattNational Center For Research Resources2005–2006
- Treatment Of Chronic Hepatitis C: Peg-Intron &RibavirinNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
